Mechanisms involved in the metastasis of cancer to bone
- PMID: 8347847
- DOI: 10.1007/BF00662140
Mechanisms involved in the metastasis of cancer to bone
Abstract
The metastasis of cancer to bone is a frequent outcome of common malignancies and is often associated with significant morbidity due to osteolysis. Bone metastasis is also selective in that a disproportionately small number of malignancies account for the majority of tumors which spread to bone. While the mechanisms of bone destruction have been studied, those responsible for the site-specific nature of bone metastasis are poorly understood. As a metastatic target, bone is unique in that it is continuously being remodelled under the influence of local and systemic growth factors, many of which are embedded in the bone matrix. This review summarizes evidence for the hypothesis that the formation of metastatic tumors in bone is the consequence of a unique microenvironment where metastatic cells can alter the metabolism of bone, thereby regulating the release of soluble bone-derived growth factors as a consequence of bone resorption. These, in turn, can modulate the malignant phenotypic properties of receptive cells. Transforming growth factor-beta is one factor which can promote the growth and motility of Walker 256 cells, a rat cell line with a propensity to metastasize spontaneously to bone.
Similar articles
-
Pathophysiologic interactions in skeletal metastasis.Cancer. 2000 Jun 15;88(12 Suppl):2912-8. doi: 10.1002/1097-0142(20000615)88:12+<2912::aid-cncr6>3.0.co;2-8. Cancer. 2000. PMID: 10898334 Review.
-
Hypoxia in bone metastasis and osteolysis.Cancer Lett. 2020 Oct 1;489:144-154. doi: 10.1016/j.canlet.2020.06.004. Epub 2020 Jun 16. Cancer Lett. 2020. PMID: 32561416 Free PMC article. Review.
-
Molecular mechanisms of tumor-bone interactions in osteolytic metastases.Crit Rev Eukaryot Gene Expr. 2000;10(2):159-78. Crit Rev Eukaryot Gene Expr. 2000. PMID: 11186331 Review.
-
TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.J Bone Miner Res. 2007 Jan;22(1):37-44. doi: 10.1359/jbmr.061005. J Bone Miner Res. 2007. PMID: 17032147
-
Mechanisms of bone metastasis.Cancer. 1997 Oct 15;80(8 Suppl):1546-56. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1546::aid-cncr4>3.3.co;2-r. Cancer. 1997. PMID: 9362421 Review.
Cited by
-
Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.Clin Exp Metastasis. 2000;18(3):253-60. doi: 10.1023/a:1006754605901. Clin Exp Metastasis. 2000. PMID: 11315099
-
Comparison of tumor curettage and resection for treatment of giant cell tumor of the bone around the knee joint.Pak J Med Sci. 2016 May-Jun;32(3):662-6. doi: 10.12669/pjms.323.9654. Pak J Med Sci. 2016. PMID: 27375710 Free PMC article.
-
Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.Br J Cancer. 1997;76(6):812-8. doi: 10.1038/bjc.1997.467. Br J Cancer. 1997. PMID: 9310251 Free PMC article.
-
Human breast cancer cell metastasis to long bone and soft organs of nude mice: a quantitative assay.Clin Exp Metastasis. 1997 Mar;15(2):173-83. doi: 10.1023/a:1018409028662. Clin Exp Metastasis. 1997. PMID: 9062394
-
LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.Clin Exp Metastasis. 1999 May;17(3):193-204. doi: 10.1023/a:1006598422203. Clin Exp Metastasis. 1999. PMID: 10432004
References
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials